首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Verfahren zur Herstellung einer Dekorscheibe ausgehend von einem transparenten Substrat
摘要
申请公布号
DE69524159(T2)
申请公布日期
2002.08.14
申请号
DE19956024159T
申请日期
1995.07.27
申请人
SAINT-GOBAIN GLASS FRANCE, COURBEVOIE
发明人
MARIS, OLIVIER;BEAUFAYS, JEAN-PIERRE;BONNET, JEAN-LOUIS
分类号
B44D2/00;B44F9/04;C03C17/00;C03C17/04;(IPC1-7):C03C17/00
主分类号
B44D2/00
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Sequence specific DNA recombination in eukaryotic cells
Substituted dihydrophenanthridinesulfonamides
Roof sheet clip assembly allowing for sliding of sheet relative to roof structure
Process to minimize loss through adhesion to equipment surfaces
Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
Collet for tube couplings with head made of stronger material than rest of collet
Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
Prefabricated concrete wall panel with top tongue and lower groove for interengagement of panels
Descent apparatus
Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
Lubricating oil compositions, comprising an amorphous olefin copolymer, which have improved friction properties
Sealable beverage bottle with a detachable fixing element to retain the closing element inserted in the bottle opening
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
Pigmented ink composition comprising a flocculating agent which is capable of forming a re-dispersible sediment of the pigment
Himbacine analogues as thrombin receptor antagonists
Small organic molecule regulators of cell proliferation
Dispensing apparatus for confectionery and the like
Method for detecting a situation of excitoxicity or neuronal stress associated with a neurodegenerative disease comprising measuring in vitro the expression of phosphodiesterase 4
